(Q44637682)

4 December 2017

title

Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women (English)

1 reference

4 December 2017

0 references

C M Banki

1

1 reference

4 December 2017

publication date

1 April 1977

1 reference

European Journal of Clinical Pharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

11

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

311-315

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00607682

4 December 2017

exact match

0 references

cites work

Thyroid-Hormone Enhancement of Imipramine in Nonretarded Depressions

1 reference

12 December 2020

Cyclic A.M.P. in depression and mania

1 reference

12 December 2020

[Clinical and neuro-endocrinological study of trh in melancholia]

1 reference

12 December 2020

INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

1 reference

12 December 2020

Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states.

1 reference

12 December 2020

3',5' cyclic adenosine monophosphate in depression and mania.

1 reference

12 December 2020

5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis

1 reference

12 December 2020

Urinary adenosine 3',5'-monophosphate excretion in affective disorders

1 reference

12 December 2020

The use of triiodothyronine in the treatment of depression

1 reference

12 December 2020

Abnormalities of indoleamines in affective disorders.

1 reference

12 December 2020

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

1 reference

12 December 2020

Interrelationships of catecholamines with other endocrine systems

1 reference

12 December 2020

Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame

1 reference

12 December 2020

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

1 reference

12 December 2020

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

1 reference

12 December 2020

Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement.

1 reference

12 December 2020

Cerebral monoamines and depression. An investigation with the Probenecid technique

1 reference

12 December 2020

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

1 reference

12 December 2020

Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid

1 reference

12 December 2020

Potentiation of Amitriptyline by Thyroid Hormone

1 reference

12 December 2020

Enhancement of Imipramine by Thyroid Stimulating Hormone: Clinical and Theoretical Implications

1 reference

12 December 2020

Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine

1 reference

12 December 2020

Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine

1 reference

12 December 2020

Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid

1 reference

12 December 2020

Thyroid Hormone and Tricyclic Antidepressants in Resistant Depressions

1 reference

12 December 2020

1 reference

12 December 2020

Urinary cyclic AMP IN 'ENDOGENOUS' AND 'NEUROTIC' DEPRESSION.

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Enhancement of imipramine antidepressant activity by thyroid hormone

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00607682

1 reference

4 December 2017

1 reference